| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/29/1992 | WO1992008739A1 Antibodies that bind to a ligand-induced binding site on integrin and induce integrin activation |
| 05/29/1992 | WO1992008737A1 NEW HUMAN RECOMBINANT η INTERFERON |
| 05/29/1992 | WO1992008735A1 Novel cytokine |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008698A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/29/1992 | WO1992008486A1 Avirulent microbes and uses therefor: salmonella typhi |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | WO1992008479A1 Tissue factor based prothrombin time reagent |
| 05/29/1992 | WO1992008478A1 Method of enhancing long-term storage stability of hemoglobin products |
| 05/29/1992 | WO1992008476A1 Peptides that inhibit platelet binding of adhesion molecules |
| 05/29/1992 | WO1992008472A1 Antithrombosis agents |
| 05/29/1992 | WO1992006199A3 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides |
| 05/29/1992 | CA2101759A1 Antithrombosis agents |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2095840A1 Cytokine |
| 05/29/1992 | CA2074476A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | CA2056222A1 Peptide compound, pharmaceutical composition and feed additive for animal |
| 05/29/1992 | CA2056143A1 The mac-1 binding site of icam-1 |
| 05/27/1992 | WO1992009633A1 Immunoglobulin-binding proteins and recombinant dna molecules coding therefor |
| 05/27/1992 | EP0487512A1 Production of heterodimeric human fertility hormones |
| 05/27/1992 | EP0487480A2 Method for the manufacture of proteaseinhibitors from potato-fruitwater |
| 05/27/1992 | EP0487410A2 Endothelin antagonists |
| 05/27/1992 | EP0487298A2 Human gamma interferon antagonist/agonist screen |
| 05/27/1992 | EP0487289A2 Cyclosporin immunoassay |
| 05/27/1992 | EP0487270A2 HIV protease inhibitors having polyether substituents |
| 05/27/1992 | EP0487238A2 A method for blocking platelet adhesion to collagen |
| 05/27/1992 | EP0487229A1 A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene |
| 05/27/1992 | EP0487116A1 Biologically active PDGF analogs in eucaryotic cells |
| 05/27/1992 | EP0487099A2 Bacteriorhodopsine - double mutants |
| 05/27/1992 | EP0487091A2 Optical isomer separating agents |
| 05/27/1992 | EP0486948A2 Retroviral protease inhibiting compounds |
| 05/27/1992 | EP0486917A2 Antiviral activity from the rep gene of adenoassociated virus-2 |
| 05/27/1992 | EP0486908A2 TNF-Muteins |
| 05/27/1992 | EP0486862A1 Chimeric fibroblast growth factor |
| 05/27/1992 | EP0486861A1 Active fragments of fibroblast growth factor |
| 05/27/1992 | EP0486627A1 Trypanosoma cruzi recombinant antigens and synthetic peptides for utilization inthe immunological diagnosis of chagas disease |
| 05/27/1992 | EP0486622A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/27/1992 | EP0486584A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | EP0486562A1 Mutant pseudorabies virus, and vaccines containing the same |
| 05/27/1992 | EP0486526A1 Tumour necrosis factor binding ligands. |
| 05/27/1992 | EP0486507A1 Anthelmintic non-living vaccine |
| 05/27/1992 | EP0486495A1 Expression system for actinomycetes and related organisms |
| 05/27/1992 | DE4037196A1 Verfahren zur reaktivierung von denaturiertem protein A process for the reactivation of denatured protein |
| 05/27/1992 | DE4036855C1 Plasmid DNA (DSM-6237) and expression vectors - encoding human gamma interferon prodn., prepd. by cleavage of c-DNA |
| 05/27/1992 | CN1016795B Production of hemopoietin |
| 05/27/1992 | CA2096953A1 Immunoglobulin-binding proteins and recombinant dna molecules coding therefor |
| 05/26/1992 | US5116965 Methods of obtaining histidine-rich protein genes of Plasmodia, and DNA obtained therefrom |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116962 Material for affinity chromatography which is a sulfated polysaccharide bonded to an insoluble polymer |
| 05/26/1992 | US5116952 Protein active in humoral hypercalcemia of malignancy-pthrp |
| 05/26/1992 | US5116951 Substantially pure interleukin-9 receptor and uses thereof |
| 05/26/1992 | US5116949 Benzoyl urea compound-albumin complex |
| 05/26/1992 | US5116948 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 05/26/1992 | US5116946 Synthetic, immunologically active peptides useful for the preparation of antimalarial vaccines |
| 05/26/1992 | US5116943 Oxidation resistant proteins |
| 05/26/1992 | US5116942 Protein having an inflammatory phospholipase a2 inhibitory activity |
| 05/26/1992 | US5116835 Enzyme-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof |
| 05/26/1992 | US5116816 Immunosuppressants, antiinflammatory, parasiticides |
| 05/26/1992 | US5116755 Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein |
| 05/26/1992 | US5116750 Genetic engineering DNA technology |
| 05/26/1992 | US5116740 Method for producing native hiv gp160 |
| 05/26/1992 | US5116739 Process for the production of human apolipoprotein e, and transformed hosts and products thereof |
| 05/26/1992 | US5116738 Osteoinductive proteins; wound healing agents |
| 05/26/1992 | US5116726 Methods for removal of detergents from analytes |
| 05/26/1992 | US5116725 Colorimetric, diagnosis |
| 05/26/1992 | US5116389 Method of obtaining collagen human-skin fibers, fibers thus produced, and a compound containing them |
| 05/26/1992 | US5116368 Polypeptides with fibronectin activity |
| 05/26/1992 | CA1302005C Aminoacid derivatives as antihypertensives |
| 05/26/1992 | CA1301685C Phospholipid conjugates and their preparation |
| 05/26/1992 | CA1301677C Recombinant surface antigens of swine mycoplasma and vaccines and diagnostics based on them |
| 05/26/1992 | CA1301676C Genetic expression of somatostatin as hybrid polypeptide |
| 05/26/1992 | CA1301675C Polycistronic expression vector construction |
| 05/26/1992 | CA1301674C Pseudorabies virus recombinants and their use in the production of proteins |
| 05/26/1992 | CA1301671C Dna from duchenne muscular dystrophy gene |
| 05/24/1992 | CA2055961A1 Active fragments of fibroblast growth factor |
| 05/23/1992 | WO1992009622A1 Process for reactivating denatured protein |
| 05/22/1992 | CA2055902A1 Peptide derivatives, their preparation process, application of these new derivatives as drugs and pharmaceutical compositions containing them |
| 05/22/1992 | CA2055869A1 Optical isomer separating agents |
| 05/22/1992 | CA2055168A1 Tnf-muteins |
| 05/21/1992 | CA2096633A1 Measles virus recombinant poxvirus vaccine |
| 05/21/1992 | CA2055813A1 Cyclosporin immunoassay |
| 05/20/1992 | WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/20/1992 | EP0486478A2 Renin-inhibiting peptides |
| 05/20/1992 | EP0486214A2 Putrescine N-methyltransferase, recombinant DNA molecules encoding putrescine N-methyltrasferase, and transgenic tobacco plants with altered nicotine content |
| 05/20/1992 | EP0486193A2 A method for altering post-translational processing of tissue plasminogen activator |
| 05/20/1992 | EP0486170A1 Baculoviral expression system comprising procaryotic leader sequence |
| 05/20/1992 | EP0486106A2 Marek's disease virus vaccine |
| 05/20/1992 | EP0486001A1 Recombinant urinary trypsin inhibitor fragments and drug composition |
| 05/20/1992 | EP0485749A2 Chemical modification of antibodies for creating of immunoconjugates |
| 05/20/1992 | EP0485701A1 Insertion of DNA by modified transposons |
| 05/20/1992 | EP0485689A1 Cells growing in protein-free medium, and enhancing replication of exogenous genes |
| 05/20/1992 | EP0485611A1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof |
| 05/20/1992 | EP0485608A1 Method for obtaining polypeptides in a cell-free translation system |
| 05/20/1992 | EP0485532A1 Fucosyl transferases involved in adhesion molecule expression |
| 05/20/1992 | EP0485530A1 TGF-$g(b) PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION |
| 05/20/1992 | EP0485525A1 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin. |
| 05/20/1992 | EP0485506A1 Methods and compositions for the production of stably transformed, fertile maize plants and cells thereof |
| 05/20/1992 | EP0485497A1 Il-2 deletion mutants |